US 11925664
Intracellular genomic transplant and methods of therapy
granted A61KA61K2239/38A61K40/11
Quick answer
US patent 11925664 (Intracellular genomic transplant and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32